Chandler Robinson, CEO: Monopar Therapeutics MNPR Sell · Filed 09/28

Trade details

Type: Insider sale
Amount: $910,717.5
Shares · price: 10,450 sh · $87.15 a share
Held after: 117,873 sh
Stock: Monopar Therapeutics MNPR
Person: Chandler RobinsonCEO
Trade date: 26/09/24
Filed: 26/09/28
Days to filing: 4 days

Sold 8.1% of holdings

Share of holding sold: 8.1%

Monopar Therapeutics trades, last 26 weeks

What else happened in Monopar Therapeutics around then

Filed or reported within 30 days of the trade day · 08/25~10/24

Chandler Robinson's recent trades

Chandler RobinsonCEO
Sell10b5-1 planMonopar Therapeutics
Sell10b5-1 plan
Monopar Therapeutics
MNPR
$847.8K
9,638 sh
$847.8K
Filed 09/28
Traded 09/24
Chandler RobinsonCEO
Sell10b5-1 planMonopar Therapeutics
Sell10b5-1 plan
Monopar Therapeutics
MNPR
$744.5K
8,368 sh
$744.5K
Filed 09/28
Traded 09/24
Chandler RobinsonCEO
Sell10b5-1 planMonopar Therapeutics
Sell10b5-1 plan
Monopar Therapeutics
MNPR
$53.9K
600 sh
$53.9K
Filed 09/28
Traded 09/24
Chandler RobinsonCEO
Planned sale10b5-1 planMonopar Therapeutics
Planned sale10b5-1 plan
Monopar Therapeutics
MNPR
$2.6M
29,056 sh
$2.6M
Filed 09/24
Traded 09/24
Chandler RobinsonOther
SellMonopar Therapeutics
Sell
Monopar Therapeutics
MNPR
$35M
550,229 sh
$35M
Filed 25/09/26
Traded 25/09/24

Chandler Robinson, CEO — sold $910.7K of Monopar Therapeutics MNPR · 8.1% of holdings · 10b5-1 plan | Whalegun